Cargando…
A Case of Hypophosphatemia with Increased Urinary Excretion of Phosphorus Associated with Ibrutinib
Ibrutinib, an irreversible oral inhibitor of Bruton's tyrosine kinase, has been used in the treatment of patients with multiple hematologic malignancies. A 59-year-old male with chronic lymphocytic leukemia was treated with 420 mg/day of ibrutinib. No evidence of bruising or diarrhea was noted....
Autores principales: | Wysokinska, Ewa M., Thompson, Amanda M., Franco Palacios, Carlos R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868944/ https://www.ncbi.nlm.nih.gov/pubmed/27194982 http://dx.doi.org/10.1159/000445798 |
Ejemplares similares
-
Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella Pneumonia
por: Watanabe, Shuhei, et al.
Publicado: (2016) -
Increased Intracranial Pressure in a Boy with Gorham-Stout Disease
por: Patel, Manisha K., et al.
Publicado: (2016) -
Gastric Schwannoma Mimicking Malignant Gastrointestinal Stromal Tumor Exhibiting Increased Fluorodeoxyglucose Uptake
por: Oh, Sung Jin, et al.
Publicado: (2016) -
Stewart-Treves Syndrome: A Case Report and Review of the Literature
por: Berebichez-Fridman, Roberto, et al.
Publicado: (2016) -
Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case
por: Manneh, Ray, et al.
Publicado: (2016)